Nantahala reports 9.03% stake in Bioventus
Nantahala Capital Management, LLC, together with Wilmot B. Harkey and Daniel Mack, reports beneficial ownership of Bioventus Inc. Class A common stock on a Schedule 13G/A amendment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nantahala Capital Management, LLC, together with Wilmot B. Harkey and Daniel Mack, reports beneficial ownership of Bioventus Inc. Class A common stock on a Schedule 13G/A amendment. As of December 31, 2025, they may be deemed to beneficially own 6,047,403 shares, representing 9.03% of the outstanding Class A shares.
The reporting persons have shared power to vote and dispose of all 6,047,403 shares through funds and separately managed accounts controlled by Nantahala, and no sole voting or dispositive power. They state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Bioventus.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Bioventus (BVS) does Nantahala report in this Schedule 13G/A?
Who are the reporting persons on this Bioventus (BVS) Schedule 13G/A filing?
As of what date is the Bioventus (BVS) ownership information in this Schedule 13G/A effective?
Under what capacity are Wilmot B. Harkey and Daniel Mack reporting Bioventus (BVS) ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.